Kantarjian, Hagop http://orcid.org/0000-0002-1908-3307
Branford, Susan
Breccia, Massimo http://orcid.org/0000-0003-1163-6162
Cortes, Jorge http://orcid.org/0000-0002-8636-1071
Haddad, Fadi G.
Hochhaus, Andreas
Hughes, Timothy
Issa, Ghayas C. http://orcid.org/0000-0002-4339-8683
Jabbour, Elias http://orcid.org/0000-0003-4465-6119
Nicolini, Franck E.
Sasaki, Koji http://orcid.org/0000-0002-9140-0610
Xavier-Mahon, Francois
Article History
Received: 28 February 2024
Revised: 7 March 2024
Accepted: 11 March 2024
First Online: 26 March 2024
Competing interests
: HK reports research grants and honoraria from AbbVie, Amgen, Amphista, Ascentage, Astellas, Biologix, Curis, Daiichi-Sankyo, Immunogen, Ipsen Biopharmaceuticals, Jazz, KAHR Medical, Labcorp, Novartis, Pfizer, Shenzhen Target Rx, Stemline, Takeda. SB reports research grants from Novartis and Cepheid, and honoraria from Novartis and Qiagen. FGH has no conflict of interest to disclose. G.C.I. received consultancy or advisory role fees from Novartis, Kura Oncology, Syndax Pharmaceuticals, Abbvie and NuProbe and received research funding from Celgene, Novartis, Kura Oncology, Syndax Pharmaceuticals, Merck, Cullinan Oncology, Astex and NuProbe. EJ reports research grants and honoraria from AbbVie, Amgen, Ascentage, Astex, Autolus, Bristol Myer-Squibb, Biologix, Daiichi-Sankyo, Genentech, Jazz, Kite, Novartis, Pfizer, Shenzhen Target Rx, TERNS, Takeda. MB received honoraria from Abbvie, AOP, Bristol Myer-Squibb, GSK, Incyte, Jazz, Novartis, Pfizer. FN is a consultant for Novartis and Sun Pharma Ltd, a board entity for Novartis, Incyte Biosciences, GSK, Bristol Myers Squibb-Celgene and Pfizer, and reports institutional grants from Novartis and Incyte Biosciences Europe. FXM reports honoraria from Ascentage Pharma Group. TPH reports research grants and honoraria from Novartis, Takeda, Pfizer, Terns, and Enliven. AH reports research support by Novartis, Incyte, BMS, Pfizer, Enliven and TERNS and honoraria by Novartis and Incyte.